相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ultraviolet Sunlight Exposure During Adolescence and Adulthood and Breast Cancer Risk: A Population-based Case-Control Study Among Ontario Women
Laura N. Anderson et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Prostate cancer incidence in Australia correlates inversely with solar radiation
Tim W. Loke et al.
BJU INTERNATIONAL (2011)
Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis
Rebecca Gilbert et al.
CANCER CAUSES & CONTROL (2011)
Meta-Analyses of Vitamin D Intake, 25-Hydroxyvitamin D Status, Vitamin D Receptor Polymorphisms, and Colorectal Cancer Risk
Mathilde Touvier et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Circulating Levels of Vitamin D and Colon and Rectal Cancer: The Physicians' Health Study and a Meta-analysis of Prospective Studies
Jung Eun Lee et al.
CANCER PREVENTION RESEARCH (2011)
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma
Sara Gandini et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Vitamin D Supplementation During Pregnancy: Double-Blind, Randomized Clinical Trial of Safety and Effectiveness
Bruce W. Hollis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pretreatment Serum Concentrations of 25-Hydroxyvitamin D and Breast Cancer Prognostic Characteristics: A Case-Control and a Case-Series Study
Song Yao et al.
PLOS ONE (2011)
Serum 25-Hydroxyvitamin D and Risk of Lung Cancer in Male Smokers: A Nested Case-Control Study
Stephanie J. Weinstein et al.
PLOS ONE (2011)
MNU-induced mammary gland carcinogenesis: Chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways
Dana Macejova et al.
TOXICOLOGY LETTERS (2011)
Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II
A. Heather Eliassen et al.
BREAST CANCER RESEARCH (2011)
Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer
Rachael Z. Stolzenberg-Solomon et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
Kathy J. Helzlsouer
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Serum vitamin D levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study
Hidetoshi Mezawa et al.
BMC CANCER (2010)
Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions
Nair Lopes et al.
BMC CANCER (2010)
Meta-analysis of vitamin D, calcium and the prevention of breast cancer
Peizhan Chen et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
DNA methylation-related vitamin D receptor insensitivity in breast cancer
Radharani Marik et al.
CANCER BIOLOGY & THERAPY (2010)
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men
Christine M. Barnett et al.
CANCER CAUSES & CONTROL (2010)
Plasma 25-Hydroxyvitamin D Levels and the Risk of Colorectal Cancer: The Multiethnic Cohort Study
Christy G. Woolcott et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Vitamin D: Considerations in the Continued Development as an Agent for Cancer Prevention and Therapy
Donald L. Trump et al.
CANCER JOURNAL (2010)
Serum 25-Hydroxyvitamin D and Cancer Mortality in the NHANES III Study (1988-2006)
D. Michal Freedman et al.
CANCER RESEARCH (2010)
Epigenetic Regulation of Vitamin D 24-Hydroxylase/CYP24A1 in Human Prostate Cancer
Wei Luo et al.
CANCER RESEARCH (2010)
Constitutive Activation of the Mitogen-Activated Protein Kinase Pathway Impairs Vitamin D Signaling in Human Prostate Epithelial Cells
Zhentao Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
NHANES Monitoring of Serum 25-Hydroxyvitamin D: A Roundtable Summary
Elizabeth A. Yetley et al.
JOURNAL OF NUTRITION (2010)
Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers
William B. Grant
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2010)
A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations
John J. McGrath et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression
Maria Jesus Larriba et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
CD-ring modified vitamin D3 analogs and their superagonistic action
Guy Eelen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology
Pankaj G. Vashi et al.
NUTRITION JOURNAL (2010)
Vitamin D Pathway Gene Variants and Prostate Cancer Prognosis
Sarah K. Holt et al.
PROSTATE (2010)
An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production
William B. Grant
DERMATO-ENDOCRINOLOGY (2010)
Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study
Mazda Jenab et al.
BRITISH MEDICAL JOURNAL (2010)
Vitamin D Gene Pathway Polymorphisms and Risk of Colorectal, Breast, and Prostate Cancer
Marjorie L. McCullough et al.
Annual Review of Nutrition (2009)
Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis
Chunbo Tang et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors
Josephia R. Muindi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Vitamin D Related Genes, CYP24A1 and CYP27B1, and Colon Cancer Risk
Linda M. Dong et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Genetic Variants in the Vitamin D Receptor Are Associated with Advanced Prostate Cancer at Diagnosis: Findings from the Prostate Testing for Cancer and Treatment Study and a Systematic Review
Lina Chen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Vitamin D Pathway Gene Variants and Prostate Cancer Risk
Sarah K. Holt et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Serum Vitamin D and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Screening Trial
Rachael Z. Stolzenberg-Solomon et al.
CANCER RESEARCH (2009)
Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk
Jiyoung Ahn et al.
CARCINOGENESIS (2009)
Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk
Sara Raimondi et al.
CARCINOGENESIS (2009)
Vitamin D and differentiation in cancer
Elzbieta Gocek et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Life course sun exposure and risk of prostate cancer: Population-based nested case-control study and meta-analysis
Rebecca Gilbert et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer
C. D. Blanke et al.
INVESTIGATIONAL NEW DRUGS (2009)
EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells
Vandanajay Bhatia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Human CYP24 Catalyzing the Inactivation of Calcitriol Is Post-Transcriptionally Regulated by miR-125b
Sayaka Komagata et al.
MOLECULAR PHARMACOLOGY (2009)
Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3
P. Kaler et al.
ONCOGENE (2009)
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer
Joseph S. Chan et al.
BJU INTERNATIONAL (2008)
19-nor-1 alpha,25-dihydroxyvitamin D-2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo
Gary G. Schwartz et al.
CANCER BIOLOGY & THERAPY (2008)
Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
D. Michal Freedman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer
Steven Attia et al.
CLINICAL CANCER RESEARCH (2008)
The effect of solar UVB doses and vitamin D production, skin cancer action spectra, and smoking in explaining links between skin cancers and solid tumours
William B. Grant
EUROPEAN JOURNAL OF CANCER (2008)
RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells
Paloma Ordonez-Moran et al.
JOURNAL OF CELL BIOLOGY (2008)
Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer
Kimmie Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Serum vitamin D concentration and prostate cancer risk: A nested case-control study
Jiyoung Ahn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Iα,25-dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells
Rita E. Serda et al.
PROSTATE (2008)
Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer - results of a large case-control study
Sascha Abbas et al.
CARCINOGENESIS (2008)
Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer
Crystal N. Holick et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan
Setsuko Kinoshita et al.
INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS (2007)
Expanding role for vitamin D in chronic kidney disease:: Importance of blood 25-OH-D levels and extra-renal 1α-hydroxylase in the classical and nonclassical actions of 1α,25-dihydroxyvitamin D3
Glenville Jones
SEMINARS IN DIALYSIS (2007)
Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk
Bahar Mikhak et al.
PROSTATE (2007)
Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women
Kyungwon Oh et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer
Tomasz M. Beer et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer
Haojie Li et al.
PLOS MEDICINE (2007)
An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking
William B. Grant
INTERNATIONAL JOURNAL OF CANCER (2007)
Seasonal and geographical variations in lung cancer prognosis in Norway Does Vitamin D from the sun play a role?
Alina Carmen Porojnicu et al.
LUNG CANCER (2007)
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: A report from the ASCENT investigators
Tomasz M. Beer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors
Marwan G. Fakih et al.
CLINICAL CANCER RESEARCH (2007)
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients
Wei Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Kristin K. Deeb et al.
NATURE REVIEWS CANCER (2007)
Vitamin D intake and the risk for pancreatic cancer in two cohort studies
Halcyon G. Skinner et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells
S Marchiani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk
SI Berndt et al.
JOURNAL OF UROLOGY (2006)
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men
E Giovannucci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: A randomized clinical trial
E Colli et al.
EUROPEAN UROLOGY (2006)
Phase I/II study of 19-nor-1α-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer
GG Schwartz et al.
CLINICAL CANCER RESEARCH (2005)
Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer
TM Beer et al.
CLINICAL CANCER RESEARCH (2005)
Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues
GM Zinser et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Biological actions of extra-renal 25-hydroxyvitamin D-1α-hydroxylase and implications for chemoprevention and treatment
K Townsend et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Calcium signaling in cancer and vitamin D
IN Sergeev
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: A phase VII study
NM Tiffany et al.
JOURNAL OF UROLOGY (2005)
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells
S Murthy et al.
PROSTATE (2005)
Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population
LC Lowe et al.
EUROPEAN JOURNAL OF CANCER (2005)
The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)
E Giovannucci
CANCER CAUSES & CONTROL (2005)
Role of supplemental calcium in the recurrence of colorectal adenomas:: A metaanalysis of randomized controlled trials
A Shaukat et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling
KL Dunn et al.
BIOCHEMISTRY AND CELL BIOLOGY (2005)
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group
CM Canil et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Residential sunlight exposure is associated with a decreased risk of prostate cancer
EM John et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia
C Crescioli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Vitamin D receptor gene polymorphisms and breast cancer risk
M Guy et al.
CLINICAL CANCER RESEARCH (2004)
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries
P Tuohimaa et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Signaling pathways in intestinal development and cancer
E Sancho et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
A critical review of studies on vitamin D in relation to colorectal cancer
WB Grant et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Vitamin D, cod-liver oil, sunlight, and rickets: A historical perspective
K Rajakumar
PEDIATRICS (2003)
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
K Dalhoff et al.
BRITISH JOURNAL OF CANCER (2003)
Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2:: Antitumor activity against leukemia, myeloma, and colon cancer cells
T Kumagai et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Prostatic 25-hydroxyvitamin D-1α-hydroxylase and its implication in prostate cancer
TC Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression
AV Krishnan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer
TM Beer et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Pharmacokinetics of high-dose oral calcitriol: Results from a phase I trial of calcitriol and paclitaxel
JR Muindi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Sequence variants in the human 25-hydroxyvitamin D3 1-α-hydroxylase (CYP27B1) gene are not associated with prostate cancer risk
GA Hawkins et al.
PROSTATE (2002)
Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling
HG Pálmer et al.
JOURNAL OF CELL BIOLOGY (2001)
Insulin-like growth factor binding protein-3 mediates 1α,25-dihydroxyvitamin D3 growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1
BJ Boyle et al.
JOURNAL OF UROLOGY (2001)
Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells
CJ Narvaez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
MH Ahonen et al.
CANCER CAUSES & CONTROL (2000)
The anti-proliferative effects of 1α,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression
MJ Campbell et al.
ONCOGENE (2000)
HGBASE: a database of SNPs and other variations in and around human genes
AJ Brookes et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
